H2020HORIZONFP7
Fundacio Institut de Recerca Contra la Leucemia Josep Carreras
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 24
- As coordinator
- 14
- EU contribution (CORDIS)
- EUR 9,135,839
- Active
- 2013 to 2024
Projects
24 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| FUN-HSCTACKLING FUNCTIONAL MATURATION FOR TRANSPLANTABLE HEMATOPOIETIC STEM CELL GENERATION | HORIZON | 2024 | Coordinator | EUR 2,065,784 |
| ChroMetElucidating the role of macroH2A1.2 histone variant as a metabolic sensor in the epigenetic regulation of leukaemia cell fate. | HORIZON | 2024 | Coordinator | EUR 165,313 |
| SECUREDScaling Up secure Processing, Anonymization and generation of Health Data for EU cross border collaborative research and Innovation | HORIZON | 2023 | Participant | EUR 230,000 |
| CARxALLNext generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia | HORIZON | 2023 | Third party | Not stated |
| ALERTContribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia | HORIZON | 2023 | Coordinator | EUR 226,441 |
| StemLincIdentification and characterization of long non-coding RNAs as drivers of stemness in hematopoietic stem cells and leukemia. | HORIZON | 2023 | Coordinator | EUR 165,313 |
| THRIVETUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS | HORIZON | 2023 | Participant | EUR 899,998 |
| SIRT7-LCRole of the SIRT7-NPM-c-Myc pathway in lung cancer | HORIZON | 2023 | Coordinator | EUR 165,313 |
| PROS-VARIANTPIK3CA-Related Overgrowth Spectrum: molecular mechanisms and preclinical modelling of PIK3CA VARIANTs | H2020 | 2022 | Coordinator | EUR 160,932 |
| SENAGESenescence as a key factor in leukemogenesis and bone marrow homeostasis in aging | H2020 | 2021 | Coordinator | EUR 172,932 |
| INTERCEPT-MDSExploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells. | H2020 | 2021 | Coordinator | EUR 752,715 |
| IT4-TALLClinical translation of a novel CD1a-directed CAR for relapse/refractory cortical T-cell Acute Lymphoblastic Leukemia: feasibility, efficacy and safety | H2020 | 2021 | Coordinator | EUR 150,000 |
| cONCReTEDevelOpmeNt of Cancer RNA TherapEutics | H2020 | 2020 | Participant | EUR 110,400 |
| SirT-IMLEUMechanisms of Sirtuin-dependent regulation of immunity and leukemogenesis | H2020 | 2020 | Coordinator | EUR 172,932 |
| HifLICsAcute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | H2020 | 2019 | Coordinator | EUR 158,122 |
| IT4B-ALLTherapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | H2020 | 2019 | Coordinator | EUR 150,000 |
| CLOSERChildhood Leukemia: Overcoming distance between South America and Europe Regions | H2020 | 2019 | Participant | EUR 151,250 |
| InTheMLLrBALLInnovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | H2020 | 2018 | Coordinator | EUR 158,122 |
| HARMONYHealthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 | H2020 | 2017 | Participant | EUR 153,348 |
| INFANTLEUKEMIAGENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OF INFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA | H2020 | 2016 | Coordinator | EUR 2,000,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.